🔎 Trials Near Me

홈 › 급성 골수성 백혈병 › 미시시피

미시시피의 급성 골수성 백혈병 임상 시험

급성 골수성 백혈병 관련 연구 8개가 미시시피 내 여러 지역에서 참여자를 모집하고 있습니다.

미시시피의 도시

공식 연구 텍스트(영어)

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • 외 2개
피험자 모집 중2상
18세 ~ 59세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • 외 2개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • 외 2개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • 외 2개
피험자 모집 중2상
18세 ~ 59세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • University of Mississippi Medical Center, Jackson
피험자 모집 중3상
6 Months – 21 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT04293562

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

  • University of Mississippi Medical Center, Jackson
피험자 모집 중3상
29 Days – 21 Years · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05183035

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Univeristy of Mississippi Medical Center, Jackson
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.